Appointment booking for Dr. Barbara Ariue, MD is currently not available.Dr. Barbara Ariue, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Barbara Ariue, MD (she/her) is a Pediatrician in Loma Linda, CA with over 18 years of experience. What is your opinion of Dr. Barbara Ariue, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Barbara Ariue, MD has received over $6,830 which includes payments from the following companies:
$3,474.80 from Optinose US, Inc.
$1,940.00 from Regeneron Healthcare Solutions, Inc.
$358.68 from ALK-Abello, Inc
$222.54 from Teva Pharmaceuticals USA, Inc.
$211.52 from CSL Behring
$175.60 from Aerocrine, Inc
$87.61 from Valeant Pharmaceuticals North America LLC
$72.19 from AstraZeneca Pharmaceuticals LP
$47.31 from Shire North American Group Inc
$40.89 from Pfizer Inc.
$34.19 from Horizon Pharma plc
$28.53 from Genentech USA, Inc.
$28.32 from Mylan Specialty L.P.
$27.24 from AIMMUNE THERAPEUTICS, INC.
$19.05 from Novartis Pharmaceuticals Corporation
$18.87 from Octapharma USA, Inc.
$16.38 from sanofi-aventis U.S. LLC
$16.00 from Meda Pharmaceuticals, Inc.
$10.78 from Merck Sharp & Dohme Corporation
Payments received by Dr. Barbara Ariue, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!